Chinese medical equipment manufacturer Shenzhen Mindray Bio-Medical Electronics Co. plans to conduct a stock offering in Hong Kong. This is reported by foreign media.
Mindray has engaged Huatai Securities Co. and JPMorgan Chase & Co. to arrange a listing worth at least $1 billion.
Mindray, which has an estimated market value of 290 billion yuan ($41 billion), is among the largest companies in mainland China seeking to re-list in Hong Kong amid the Chinese government's drive to attract investors and increase asset liquidity.
According to analysts, the volume of stock sales on the Hong Kong stock market will exceed $26 billion in 2025.
Mindray is a Chinese company manufacturing medical equipment, including ventilators and defibrillators. Mindray is one of the largest publicly traded companies in China. The headquarters is located in Shenzhen (Guangdong Province, China).
Read also in our Telegram channel "Mergers and acquisitions. AK&M».
